Loading video...

Video Failed to Load

Go Home

Breakingviews columnists talk about the US government’s golden share and implications for others eyeing stateside expansion, offering a weekly dose of financial insight @AimeeDonnellan

Reuters's profile picture

Reuters

25,573,725 subscribers

26,732 views • 1 year ago •via X (Twitter)

News & PoliticsFinance
LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

In this Viewsroom podcast, Breakingviews columnists discuss how the EU can react to President Trump’s 30% levies on all exports, and why, given a so far measured response, Trump has reason to push even harder Jonathan Guilford @AimeeDonnellan
20:37

In this Viewsroom podcast, Breakingviews columnists discuss how the EU can react to President Trump’s 30% levies on all exports, and why, given a so far measured response, Trump has reason to push even harder Jonathan Guilford @AimeeDonnellan

Reuters

22,322 views • 1 year ago

In this Viewsroom podcast Breakingviews columnists explain why investors are scrambling to own companies like CoreWeave, Circle Internet Group and Chime Financial Jonathan Guilford Aimee Weber Donnellan
16:30

In this Viewsroom podcast Breakingviews columnists explain why investors are scrambling to own companies like CoreWeave, Circle Internet Group and Chime Financial Jonathan Guilford Aimee Weber Donnellan

Reuters

27,432 views • 1 year ago

In this Viewsroom debate, Breakingviews columnists discuss the AI race and why investors are willing to support a long game
25:12

In this Viewsroom debate, Breakingviews columnists discuss the AI race and why investors are willing to support a long game

Reuters

31,749 views • 1 year ago

In today's Viewsroom debate, our Breakingviews columnists decode what's happening with the Wall Street and mainstream banks around the globe in the midst of looming tariffs and stubborn inflation, and if we need to worry
26:18

In today's Viewsroom debate, our Breakingviews columnists decode what's happening with the Wall Street and mainstream banks around the globe in the midst of looming tariffs and stubborn inflation, and if we need to worry

Reuters

24,645 views • 1 year ago

🔊 Donald Trump’s health agency nominee, Robert Kennedy, brings dangerous views on vaccines as well as skepticism about sky-high medicine prices. In this episode of Viewsroom, Reuters Breakingviews columnists discuss the impact on giants like Novo Nordisk
0:53

🔊 Donald Trump’s health agency nominee, Robert Kennedy, brings dangerous views on vaccines as well as skepticism about sky-high medicine prices. In this episode of Viewsroom, Reuters Breakingviews columnists discuss the impact on giants like Novo Nordisk

Reuters

28,071 views • 1 year ago